Yocca Frank 4
4 · BioXcel Therapeutics, Inc. · Filed Jul 22, 2025
Insider Transaction Report
Form 4
Yocca Frank
Chief Scientific Officer
Transactions
- Award
Common Stock
2025-07-22+4,375→ 6,316 total
Footnotes (1)
- [F1]The Issuer previously granted the Reporting Person an award of restricted stock units that would vest based on the Issuer's satisfaction of certain performance objectives and subject to the Reporting Person's continued service with the Issuer through July 22, 2025 (the "PSUs"). On July 22, 2025, the Compensation Committee of the Issuer's Board of Directors determined that performance conditions with respect to 4,375 PSUs had been satisfied and 4,375 shares of common stock became issuable to the Reporting Person on July 22, 2025.